CTNNB1 Connect and Cure (CCC) supports several research initiatives per year to advance the understanding and treatment of CTNNB1 . We invite applications for funding on an annual or semiannual basis, in response to a Request for Applications (RFA). We also accept proposals on a rolling basis for research without a particular RFA.
CCC accepts applications in all areas of research relevant to CTNNB1 Syndrome, but we are particularly interested in supporting projects that will lead to new interventions to alleviate the symptoms associated with CTNNB1 Syndrome.
CCC accepts applications from academic, government, non-profit or for-profit research entities. Academic research applicants should have a primary faculty appointment at the level of Instructor or higher. This grant program will be useful for junior faculty in the early stages of their careers, established investigators in other areas of research who wish to enter the field of CTNNB1 Syndrome research, or investigators in the rare genetic disease field who are seeking funding to support pilot studies in a new area of CTNNB1 Syndrome research. CCC seeks to support innovative, high-risk/high reward research in its early stages.
Applications meeting the technical requirements of our RFAs are reviewed by scientific reviewers on our Science Advisory Board (SAB), who have expertise in the research area, as well as an advocate reviewer who evaluates the relevance of the proposed research to the CTNNB1 Syndrome community. Final funding decisions are based on scientific merit, relevance to CTNNB1 Syndrome, funding levels and the suitability of the research with respect to the programmatic goals of CCC.
If you have questions or would like to submit a research proposal, please contact one of our directors:
Science Director Kellan Weston, Ph.D – kellan.weston@combinedbrain.org
Research Director Tony King – tony@curectnnb1.org